Phazyme Capsule, Gelatin Coated
NDC Package 0132-0208-84
Package Information
Phazyme (simethicone) capsules is a medication used to relieve symptoms of extra gas such as belching, bloating, and feelings of pressure/discomfort in the stomach/gut. This formulation utilizes a capsule, gelatin coated delivery system. Marketed by C.b. Fleet Company, Inc., this product is identified by NDC 0132-0208 and is authorized under FDA application M002.
Identification & Billing
- RxCUI: 252294 - simethicone 180 MG Oral Capsule
- RxCUI: 252294 - dimethicone 180 MG Oral Capsule
- RxCUI: 352091 - PhaZyme Ultra Strength 180 MG Oral Capsule
- RxCUI: 352091 - simethicone 180 MG Oral Capsule [Phazyme]
- RxCUI: 352091 - Phazyme 180 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0132 - C.b. Fleet Company, Inc.
- 0132-0208 - Phazyme
- 0132-0208-84 - 1 BOTTLE in 1 BOX / 48 CAPSULE, GELATIN COATED in 1 BOTTLE
- 0132-0208 - Phazyme
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0132-0208). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0132-0208-84 identifies a specific commercial package of 1 bottle in 1 box / 48 capsule, gelatin coated in 1 bottle of Phazyme, a human over the counter drug labeled by C.b. Fleet Company, Inc.. This capsule, gelatin coated is formulated for oral use and contains dimethicone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by C.b. Fleet Company, Inc. on February 01, 2012. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This product is used to relieve symptoms of extra gas such as belching, bloating, and feelings of pressure/discomfort in the stomach/gut. Simethicone helps break up gas bubbles in the gut.
How is this C.b. Fleet Company, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00132020884. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.